IBDEI0QB ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34821,0)
 ;;=C62.90^^100^1507^161
 ;;^UTILITY(U,$J,358.3,34821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34821,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,34821,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,34821,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,34822,0)
 ;;=D03.9^^100^1507^165
 ;;^UTILITY(U,$J,358.3,34822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34822,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,34822,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,34822,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,34823,0)
 ;;=C45.0^^100^1507^166
 ;;^UTILITY(U,$J,358.3,34823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34823,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,34823,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,34823,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,34824,0)
 ;;=C90.01^^100^1507^168
 ;;^UTILITY(U,$J,358.3,34824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34824,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,34824,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,34824,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,34825,0)
 ;;=C90.00^^100^1507^169
 ;;^UTILITY(U,$J,358.3,34825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34825,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,34825,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,34825,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,34826,0)
 ;;=C94.6^^100^1507^170
 ;;^UTILITY(U,$J,358.3,34826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34826,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,34826,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,34826,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,34827,0)
 ;;=D61.82^^100^1507^171
 ;;^UTILITY(U,$J,358.3,34827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34827,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,34827,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,34827,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,34828,0)
 ;;=D47.9^^100^1507^172
 ;;^UTILITY(U,$J,358.3,34828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34828,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,34828,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,34828,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,34829,0)
 ;;=D53.9^^100^1507^176
 ;;^UTILITY(U,$J,358.3,34829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34829,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,34829,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,34829,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,34830,0)
 ;;=D47.4^^100^1507^177
 ;;^UTILITY(U,$J,358.3,34830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34830,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,34830,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,34830,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,34831,0)
 ;;=D59.1^^100^1507^28
 ;;^UTILITY(U,$J,358.3,34831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34831,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,34831,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,34831,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,34832,0)
 ;;=D51.3^^100^1507^191
 ;;^UTILITY(U,$J,358.3,34832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34832,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,34832,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,34832,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,34833,0)
 ;;=D77.^^100^1507^57
 ;;^UTILITY(U,$J,358.3,34833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34833,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,34833,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,34833,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,34834,0)
 ;;=D58.2^^100^1507^83
 ;;^UTILITY(U,$J,358.3,34834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34834,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,34834,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,34834,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,34835,0)
 ;;=C88.8^^100^1507^103
 ;;^UTILITY(U,$J,358.3,34835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34835,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,34835,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,34835,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,34836,0)
 ;;=D70.8^^100^1507^174
 ;;^UTILITY(U,$J,358.3,34836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34836,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,34836,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,34836,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,34837,0)
 ;;=D59.4^^100^1507^175
 ;;^UTILITY(U,$J,358.3,34837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34837,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,34837,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,34837,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,34838,0)
 ;;=D69.59^^100^1507^181
 ;;^UTILITY(U,$J,358.3,34838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34838,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,34838,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,34838,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,34839,0)
 ;;=C22.7^^100^1507^46
 ;;^UTILITY(U,$J,358.3,34839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34839,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,34839,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,34839,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,34840,0)
 ;;=D75.89^^100^1507^56
 ;;^UTILITY(U,$J,358.3,34840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34840,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,34840,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,34840,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,34841,0)
 ;;=D47.Z9^^100^1507^173
 ;;^UTILITY(U,$J,358.3,34841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34841,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,34841,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,34841,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,34842,0)
 ;;=D05.82^^100^1507^34
 ;;^UTILITY(U,$J,358.3,34842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34842,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,34842,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,34842,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,34843,0)
 ;;=D05.81^^100^1507^36
 ;;^UTILITY(U,$J,358.3,34843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34843,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,34843,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,34843,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,34844,0)
 ;;=D05.80^^100^1507^38
 ;;^UTILITY(U,$J,358.3,34844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34844,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,34844,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,34844,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,34845,0)
 ;;=D56.8^^100^1507^186
 ;;^UTILITY(U,$J,358.3,34845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34845,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,34845,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,34845,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,34846,0)
 ;;=C82.89^^100^1507^76
 ;;^UTILITY(U,$J,358.3,34846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34846,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,34846,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,34846,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,34847,0)
 ;;=D51.8^^100^1507^193
 ;;^UTILITY(U,$J,358.3,34847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34847,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,34847,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,34847,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,34848,0)
 ;;=I80.9^^100^1507^178
 ;;^UTILITY(U,$J,358.3,34848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34848,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,34848,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,34848,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,34849,0)
 ;;=D45.^^100^1507^179
 ;;^UTILITY(U,$J,358.3,34849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34849,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,34849,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,34849,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,34850,0)
 ;;=C77.3^^100^1507^109
 ;;^UTILITY(U,$J,358.3,34850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34850,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,34850,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,34850,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,34851,0)
 ;;=C77.2^^100^1507^125
 ;;^UTILITY(U,$J,358.3,34851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34851,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,34851,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,34851,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,34852,0)
 ;;=C77.1^^100^1507^126
 ;;^UTILITY(U,$J,358.3,34852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34852,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,34852,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,34852,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,34853,0)
 ;;=C77.0^^100^1507^142
 ;;^UTILITY(U,$J,358.3,34853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34853,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,34853,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,34853,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,34854,0)
 ;;=C77.8^^100^1507^143
 ;;^UTILITY(U,$J,358.3,34854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34854,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,34854,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,34854,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,34855,0)
 ;;=C79.51^^100^1507^113
 ;;^UTILITY(U,$J,358.3,34855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34855,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,34855,1,4,0)
 ;;=4^C79.51
